Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus-16 Positive”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Early research (Phase 1)Not Yet RecruitingNCT06358053
What this trial is testing

CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers

Who this might be right for
Cervical CancerAnal CancerHead and Neck Cancers+1 more
Corregene Biotechnology Co., Ltd 24
Testing effectiveness (Phase 2)Study completedNCT00091130
What this trial is testing

SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells

Who this might be right for
Atypical Squamous Cells of Undetermined SignificanceCervical CancerHigh-grade Squamous Intraepithelial Lesion+1 more
National Cancer Institute (NCI) 139
Not applicableUnknownNCT02411019
What this trial is testing

Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Genexine, Inc. 67
Early research (Phase 1)UnknownNCT05895370
What this trial is testing

HPV-T in HPV-16 Positive Recurrent or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
BGI, China 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03260023
What this trial is testing

Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

Who this might be right for
HPV-Related CarcinomaHPV-Related Cervical CarcinomaHPV-Related Anal Squamous Cell Carcinoma+2 more
Transgene 143
Early research (Phase 1)Study completedNCT02379520
What this trial is testing

HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA

Who this might be right for
Human Papillomavirus-Related CarcinomaHuman Papillomavirus Positive Oropharyngeal CarcinomaHuman Papillomavirus Positive Cervical Carcinoma+3 more
Baylor College of Medicine 32
Not applicableUnknownNCT06097936
What this trial is testing

New Prognostic and Predictive Biomarkers for HPV-associated Oropharyngeal Cancer

Who this might be right for
PREDICTIVE BIOMARKERSEvaluation of HPV-specific E5 Transcript Expression in a Cohort of Patients With HPV-associated OPCHPV 16 Positive Oropharyngeal Tumors (OPC)
Regina Elena Cancer Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT04852328
What this trial is testing

Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma
Washington University School of Medicine 30
Not applicableStudy completedNCT02016833
What this trial is testing

Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity

Who this might be right for
Ovarian Serous AdenocarcinomaUndifferentiated Carcinoma of OvaryCervical Cancer+3 more
PX Biosolutions 15
Testing effectiveness (Phase 2)Study completedNCT04180215
What this trial is testing

A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

Who this might be right for
HPV-Related Squamous Cell Carcinoma
Hookipa Biotech GmbH 198
Testing effectiveness (Phase 2)Looking for participantsNCT07175662
What this trial is testing

Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL

Who this might be right for
High-grade Squamous Intraepithelial Lesion (HSIL)
Newish Biotech (Wuxi) Co., Ltd. 150
Testing effectiveness (Phase 2)WithdrawnNCT04536922
What this trial is testing

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab

Who this might be right for
Metastatic HPV-16 Positive Squamous Cell Anal Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT04646005
What this trial is testing

Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy

Who this might be right for
Cervical Cancer
Regeneron Pharmaceuticals 113
Early research (Phase 1)Active Not RecruitingNCT05973487
What this trial is testing

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerCervical CancerNon-small Cell Carcinoma+18 more
TScan Therapeutics, Inc. 840
Testing effectiveness (Phase 2)Study completedNCT04405349
What this trial is testing

Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer

Who this might be right for
Cervical CancerCervix Cancer
Nykode Therapeutics ASA 52
Not applicableEnded earlyNCT05061940
What this trial is testing

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

Who this might be right for
Head and Neck CancerMelanomaHPV-Related Malignancy+5 more
Repertoire Immune Medicines 22
Very early researchEnded earlyNCT04630353
What this trial is testing

A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer

Who this might be right for
HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer
Hookipa Biotech GmbH 10
Early research (Phase 1)Ended earlyNCT03815682
What this trial is testing

RPTR-147 in Patients With Selected Solid Tumors and Lymphomas

Who this might be right for
Solid TumorLymphoma
Repertoire Immune Medicines 23
Not applicableUnknownNCT05905354
What this trial is testing

Clinical Study of HPV Therapeutic DNA Vaccine (NWRD08) in Patients With Cervical HPV16 and/or HPV18 Positive

Who this might be right for
HSIL of Cervix
Newish Technology (Beijing) Co., Ltd. 12
Not applicableLooking for participantsNCT06741150
What this trial is testing

NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.

Who this might be right for
Intraepithelial NeoplasiaCervical Cancer
Newish Technology (Beijing) Co., Ltd. 18
Load More Results